C. Kaehler (Innsbruck, Austria), G. Lungarella (Siena, Italy)
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients R. Annoni, T. Lancas, S. Battaglia, L. Silva, M. Dolhnikoff, A. Bruno, S. Fernezlian, P. Hiemstra, P. Sterk, K. Rabe, T. Mauad (Sao Paulo, Brazil; Palermo, Italy; Leiden, Amsterdam, Netherlands)
| |
PDE4 inhibition prevents corticosteroid-resistant lung inflammation induced by cigarette smoke exposure in mice C. Carnini, P. Caruso, A. R. Pisano, F. Bassani, M. Civelli, G. Villetti (Parma, Italy)
| |
Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice S. Cardini, M. Lucattelli, S. Fineschi, M. Perretti, G. Cirino, G. Lungarella (Siena, Naples, Italy; London, United Kingdom)
| |
Identifying the sputum and BALF cell subpopulation with somatic DNA alterations in COPD K. Samara, E. Tzortzaki, E. Neofytou, N. Tzanakis, N. Siafakas (Heraklion, Greece)
| |
Human prohibitin 1 (hPH1) protein overexpression in COPD: preliminary results E. Tzortzaki, M. Psarrou, A. Koutsopoulos, S. Schiza, E. Neofytou, D. Papandrinopoulou, V. Tzilas, N. Siafakas (Heraklion, Greece)
| |
Vascular and basement membrane remodelling in smokers and COPD A. Soltani, D. Reid, S. S. Sohal, H. K. Muller, S. Weston, R. Wood-Baker, E. H. Walters (Hobart, Australia)
| |
Role of p21 (WAF1/Cip1) in the remodelling of the airway epithelium in smoker +/- COPD subjects G. Chiappara, E. Pace, A. M. Montalbano, M. Ferraro, A. Bruno, M. Profita, M. I. Minervini, P. Vitulo, L. Pipitone, B. Gridelli, M. Gjomarkaj (Palermo, Italy)
| |
Modified sensitivity of alveolar cells to TRAIL-mediated apoptosis: a mechanism involved in emphysema pathogenesis with a potential impact on cancer therapy research M. C. Morissette, J. Parent, J. Milot (Quebec City, Canada)
| |
Higher sensitivity of the emphysematous lung to TRAIL-mediated apoptosis M. C. Morissette, J. Parent, J. Milot (Quebec, Canada)
| |
Differential response to stretch in different lung cells is related to differences in pi3k signalling S. Hammerschmidt, H. Kuhn, H. J. Seyfarth, C. Geßner, S. Heyder, H. Wirt (Leipzig, Germany)
| |
Viability of human alveolar epithelial cells type II under biaxial cyclic stretch S. J. Schließmann, K. Höhne, A. Charra, S. Schumann, A. Kirschbaum, G. Zissel, J. Guttmann (Freiburg, Germany)
| |
High concentrations of VEGF reduce stretch-induced apoptosis of alveolar type II cells H. Kuhn, S. Krüger, S. Hammerschmidt, H. Wirtz (Leipzig, Germany)
| |
Development of animal model of high altitude pulmonary edema in exercising rats exposed to hypobaric hypoxia J. She, L. Gao, Y. L. Song, C. X. Bai (Shanghai, China; San Francisco, United States Of America)
| |
Hypoxia impairs β2 adrenergic signalling and stimulation of alveolar reabsorption in rat alveolar epithelial cells E. Baloglu, B. Loeh, P. Bärtsch, H. Mairbäurl (Heidelberg, Germany)
| |
Modulation of ventilator-induced lung injury in rats by sodium nitrite P. A. Pickerodt, M. J. Emery, W. J. Martin, R. C. E. Francis, E. R. Swenson (Berlin, Germany; Seattle, Boston, United States Of America)
| |
PKA- and Epac/Rap-dependent mechanisms of lung endothelial barrier protection in acute lung injury A. Birukova, D. Burdette, P. Fu, K. Birukov (Chicago, United States Of America)
| |
ATF3 is activated in ventilator induced lung injury (VILI) A. Akram, J. Haitsma, H. Zhang, M. Y. Liu, A. Slutsky, C. Dos Santos (Toronto, Canada)
| |
Cysteinyl leukotrienes cause down-regulation of β-tubulin isotype IV in human bronchial epithelial cells S. Altraja, J. Jaama, A. Altraja (Tartu, Estonia)
| |
Targeting of endothelial progenitor cells with the proteasome inhibitor bortezomib K. Cima, J. Loeffler-Ragg, T. Resch, G. Gamerith, I. Skvortsova, C. M. Kähler (Innsbruck, Austria)
| |
Effects of the PDE4 inhibitor roflumilast n-oxide on the adherence of polymorphonuclear cells (PMNC) to bronchial epithelial cells (BEAS-2B) induced by non-typeable Haemophilus influenzae S. Boreo, L. Petecchia, F. Sabatini, M. Silvestri, G. Rossi (Genoa, Italy)
| |